Literature DB >> 21553323

Natural history of adolescent-onset cystinosis.

Julian P Midgley1, Reyhan El-Kares, François Mathieu, Paul Goodyer.   

Abstract

Cystinosis is a rare autosomal recessive disease caused by mutations of the CTNS gene in which cystine accumulates throughout the body as a result of a defective efflux of cystine from lysosomes. Three phenotypic forms have been described according to the age of onset and the severity of the clinical symptoms: infantile, intermediate, and ocular non-nephropathic cystinosis. Here we report the natural history of cystinosis in a 55-year-old man with intermediate nephropathic cystinosis diagnosed at 9 years of age. Although tubulopathy was unnoticed in the early years, he required transplantation at age 16. Sequencing analysis of all the CTNS exons revealed that the proband is homozygous for a 21-bp in-frame deletion in exon 5 (c. 198_218del21), resulting in an in-frame deletion of 7 amino acids from the N-terminal domain of the cystinosin protein. Our patient has had relatively mild extra-renal disease despite lack of early cysteamine therapy. He has been able to attend university and pursue a professional career into the 6th decade.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21553323     DOI: 10.1007/s00467-011-1904-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

1.  Adolescent cystinosis: comparisons with infantile and adult forms.

Authors:  H Goldman; C R Scriver; K Aaron; E Delvin; Z Canlas
Journal:  Pediatrics       Date:  1971-06       Impact factor: 7.124

2.  Mutations of CTNS causing intermediate cystinosis.

Authors:  J Thoene; R Lemons; Y Anikster; J Mullet; K Paelicke; C Lucero; W Gahl; J Schneider; S G Shu; H T Campbell
Journal:  Mol Genet Metab       Date:  1999-08       Impact factor: 4.797

3.  Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin.

Authors:  M Attard; G Jean; L Forestier; S Cherqui; W van't Hoff; M Broyer; C Antignac; M Town
Journal:  Hum Mol Genet       Date:  1999-12       Impact factor: 6.150

4.  The molecular basis of Dutch infantile nephropathic cystinosis.

Authors:  S G Heil; E Levtchenko; L A Monnens; F J Trijbels; N M Van der Put; H J Blom
Journal:  Nephron       Date:  2001-09       Impact factor: 2.847

5.  A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis.

Authors:  M Town; G Jean; S Cherqui; M Attard; L Forestier; S A Whitmore; D F Callen; O Gribouval; M Broyer; G P Bates; W van't Hoff; C Antignac
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

6.  Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy.

Authors:  Barbara C Sonies; Phaedra Almajid; Robert Kleta; Isa Bernardini; William A Gahl
Journal:  Medicine (Baltimore)       Date:  2005-05       Impact factor: 1.889

7.  CTNS mutations in an American-based population of cystinosis patients.

Authors:  V Shotelersuk; D Larson; Y Anikster; G McDowell; R Lemons; I Bernardini; J Guo; J Thoene; W A Gahl
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

8.  Complications of nephropathic cystinosis after renal failure.

Authors:  W A Gahl; M I Kaiser-Kupfer
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

9.  Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy.

Authors:  William A Gahl; Joan Z Balog; Robert Kleta
Journal:  Ann Intern Med       Date:  2007-08-21       Impact factor: 25.391

10.  Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosin.

Authors:  Vasiliki Kalatzis; Nathalie Nevo; Stéphanie Cherqui; Bruno Gasnier; Corinne Antignac
Journal:  Hum Mol Genet       Date:  2004-05-05       Impact factor: 6.150

View more
  3 in total

1.  Impact of Cystinosin Glycosylation on Protein Stability by Differential Dynamic Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC).

Authors:  Nathalie Nevo; Lucie Thomas; Cerina Chhuon; Zuzanna Andrzejewska; Joanna Lipecka; François Guillonneau; Anne Bailleux; Aleksander Edelman; Corinne Antignac; Ida Chiara Guerrera
Journal:  Mol Cell Proteomics       Date:  2017-01-12       Impact factor: 5.911

2.  The novel aminoglycoside, ELX-02, permits CTNSW138X translational read-through and restores lysosomal cystine efflux in cystinosis.

Authors:  Emma J Brasell; Lee Lee Chu; Murielle M Akpa; Idit Eshkar-Oren; Iris Alroy; Rachel Corsini; Brian M Gilfix; Yojiro Yamanaka; Pedro Huertas; Paul Goodyer
Journal:  PLoS One       Date:  2019-12-04       Impact factor: 3.240

Review 3.  Genetic burden linked to founder effects in Saguenay-Lac-Saint-Jean illustrates the importance of genetic screening test availability.

Authors:  Mbarka Bchetnia; Luigi Bouchard; Jean Mathieu; Philippe M Campeau; Charles Morin; Diane Brisson; Anne-Marie Laberge; Hélène Vézina; Daniel Gaudet; Catherine Laprise
Journal:  J Med Genet       Date:  2021-04-28       Impact factor: 6.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.